$LGIQ
LOGIQ, INC.

2024 Q2 Form 10-K Financial Statement

#000157587224000488 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Gross Profit $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Gross Profit Margin
Selling, General & Admin $215.5K $16.05M $16.05M
YoY Change -94.06% 2472.15% -12.76%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization $0.00 -$1.136M $363.8K
YoY Change -100.0% -114.36% 430.76%
% of Gross Profit
Operating Expenses $215.5K $16.41M $16.41M
YoY Change -94.68% 37.62% -70.22%
Operating Profit -$215.5K -$16.41M -$16.41M
YoY Change -93.88% 44.96% -66.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Pretax Income -$215.5K -$16.41M -$16.41M
YoY Change -93.96% -47.11% -66.62%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$215.5K -$20.10M -$20.10M
YoY Change -93.96% -35.23% -59.12%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$0.20 -$0.20
COMMON SHARES
Basic Shares Outstanding 219.8M 147.0M 100.4M
Diluted Shares Outstanding 143.9M 100.4M

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.590K $16.86K $16.86K
YoY Change -98.04% -96.43% -96.43%
Cash & Equivalents $9.587K $16.86K $16.86K
Short-Term Investments
Other Short-Term Assets $146.8K $152.0K $152.0K
YoY Change -48.0% -45.66% -45.66%
Inventory
Prepaid Expenses $146.8K $152.0K
Receivables
Other Receivables $449.4K $482.4K
Total Short-Term Assets $605.8K $651.3K $651.3K
YoY Change -71.05% -72.88% -72.88%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $605.8K $651.3K $651.3K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $605.8K $651.3K $651.3K
YoY Change -95.68% -95.71% -95.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $741.3K $992.0K $992.0K
YoY Change -76.43% -80.45% -80.45%
Accrued Expenses $47.00K $50.00K $50.00K
YoY Change -97.92% -97.71% -97.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $788.3K $1.042M $1.042M
YoY Change -85.4% -86.14% -86.14%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $788.3K $1.042M $1.042M
Total Long-Term Liabilities $10.00K $10.00K $10.00K
Total Liabilities $798.3K $1.052M $1.052M
YoY Change -85.24% -86.03% -86.03%
SHAREHOLDERS EQUITY
Retained Earnings -$132.7M -$131.8M
YoY Change -10.0% 0.3%
Common Stock $27.80K $14.39K
YoY Change 189.98% 160.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$192.6K -$400.7K -$400.7K
YoY Change
Total Liabilities & Shareholders Equity $605.8K $651.3K $651.3K
YoY Change -95.68% -95.71% -95.71%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$215.5K -$20.10M -$20.10M
YoY Change -93.96% -35.23% -59.12%
Depreciation, Depletion And Amortization $0.00 -$1.136M $363.8K
YoY Change -100.0% -114.36% 430.76%
Cash From Operating Activities -$595.4K $992.9K -$17.94M
YoY Change -81.42% -120.92% 14.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $21.00K -$2.420K -$482.4K
YoY Change -81.49% -106.69%
Cash From Investing Activities $21.00K -$2.420K -$482.4K
YoY Change -81.49% -106.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $18.22M
YoY Change 141.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 533.1K -1.366M 17.96M
YoY Change -81.16% -128.27% 142.73%
NET CHANGE
Cash From Operating Activities -595.4K 992.9K -17.94M
Cash From Investing Activities 21.00K -2.420K -482.4K
Cash From Financing Activities 533.1K -1.366M 17.96M
Net Change In Cash -41.33K -375.3K -455.3K
YoY Change -84.22% -547.21% -59.13%
FREE CASH FLOW
Cash From Operating Activities -$595.4K $992.9K -$17.94M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Trading Symbol
TradingSymbol
lgiq
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001335112
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Security Exchange Name
SecurityExchangeName
NONE
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-51815
CY2023 dei Entity Registrant Name
EntityRegistrantName
LOGIQ, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5057897
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
230 Victoria Street Bugis Junction
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
#15-01/08
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
CY2023 dei Entity Address Country
EntityAddressCountry
SG
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
188024
CY2023 dei City Area Code
CityAreaCode
+65
CY2023 dei Local Phone Number
LocalPhoneNumber
9366 2322
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
25465605
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
219786751
CY2023 dei Auditor Name
AuditorName
Centurion ZD CPA & Co.
CY2023 dei Auditor Location
AuditorLocation
Hong Kong
CY2023 dei Auditor Firm
AuditorFirmId
2769
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
363799
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
12418668
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12782467
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
152000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
190000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
482420
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16858
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19878
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2191673
CY2023Q4 us-gaap Assets Current
AssetsCurrent
651278
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2401551
CY2023Q4 us-gaap Assets
Assets
651278
CY2022Q4 us-gaap Assets
Assets
15184018
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
991958
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
965140
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
50000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
445191
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
260220
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
5849466
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1041958
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7520017
CY2023Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2023Q4 us-gaap Liabilities
Liabilities
1051958
CY2022Q4 us-gaap Liabilities
Liabilities
7530017
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
14386
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5512
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
109364314
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94829417
CY2023Q4 lgiq Capital Reserves
CapitalReserves
22029969
CY2022Q4 lgiq Capital Reserves
CapitalReserves
24532194
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131809349
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111713122
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-400680
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
651278
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15184018
CY2023 us-gaap Revenues
Revenues
0
CY2022 us-gaap Revenues
Revenues
0
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2023 lgiq Gross Income
GrossIncome
0
CY2022 lgiq Gross Income
GrossIncome
0
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
363799
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125133
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15891405
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6913719
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
154715
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2887525
CY2023 us-gaap Operating Expenses
OperatingExpenses
16409919
CY2022 us-gaap Operating Expenses
OperatingExpenses
9951377
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16409919
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-9951377
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2023 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-16409919
CY2022 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-9951377
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-16409919
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9951377
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3686308
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-19511632
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-20096227
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-29463009
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.1635
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.1635
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.2821
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.2821
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.0367
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.0367
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.5531
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.5531
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100388763
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100388763
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35277343
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35277343
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-20096227
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-29463009
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3686308
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-19511632
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-16409919
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9951377
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
363799
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
125133
CY2023 lgiq Gain Loss On Deconsolidation Of Subsidiary
GainLossOnDeconsolidationOfSubsidiary
-604974
CY2022 lgiq Gain Loss On Deconsolidation Of Subsidiary
GainLossOnDeconsolidationOfSubsidiary
0
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-38000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-332118
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
26817
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
312244
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-395191
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
159000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16981468
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9022882
CY2023 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-955686
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-6701439
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17937154
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15724321
CY2023 lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
0
CY2022 lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
-7208700
CY2023 lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
0
CY2022 lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
-681
CY2023 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
482420
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-482420
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7209381
CY2023 lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-260220
CY2022 lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-140808
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18224446
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7541689
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17964226
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7400881
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-455348
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1114059
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
472206
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586265
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16858
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
472206
CY2023 lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
14653610
CY2022 lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
10840852
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29575321
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7541702
CY2022 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
-13
CY2022 us-gaap Profit Loss
ProfitLoss
-29463009
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12041946
CY2023 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
-400
CY2023 us-gaap Profit Loss
ProfitLoss
-20096227
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-400680
CY2021Q4 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
GoLogiq is a fully reporting U.S. public company. In connection with the Separation, the Company announced that it intended to distribute, on a pro rata basis, 100%
CY2022Q1 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
The Company held the GoLogiq Shares until it distributed 100% of the GoLogiq Shares to the Company’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof will receive 1 share of Lovarra)
CY2023 lgiq Data Logiq Spinoff Description
DataLogiqSpinoffDescription
At Closing Abri will deliver to the Company $114 million worth of shares Abri common stock, par value $0.0001, at $10.00 per share (the “Merger Consideration Shares”). Also at Closing, the Company will issue a dividend to its shareholders on a pro-rata basis equal to 25% of the aggregate Merger Consideration Shares (the “Dividend Shares”), payable to the Company shareholders of record as of a record date to be set shortly before Closing.
CY2023Q2 us-gaap Tangible Capital Required For Capital Adequacy
TangibleCapitalRequiredForCapitalAdequacy
5000001
CY2023Q3 lgiq Percentage Of Merger Consideration Shares Required To Distribute
PercentageOfMergerConsiderationSharesRequiredToDistribute
0.14
CY2023Q4 us-gaap Shares Issued
SharesIssued
3762000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16409919
CY2023 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
17937154
CY2023Q4 lgiq Working Capital Deficit
WorkingCapitalDeficit
-390680
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131809349
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;">USE OF ESTIMATES</div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;">The preparation of the Company’s financial statements in conformity with generally accepted accounting principles of the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Actual results could differ from those estimates.</div></div>
CY2023 lgiq Operating Segments
OperatingSegments
0.10
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;">ACCOUNTS RECEIVABLE AND CONCENTRATION OF RISK</div></div><div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none; text-indent: 0px; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px; line-height: 12pt;display:inline;">Accounts receivable consists of trade receivables from customers. The Company records accounts receivable at its net realizable value, recognizing an allowance for doubtful accounts based on our best estimate of probable credit losses on our existing accounts receivable. Balances are written off against the allowance after all means of collection have been exhausted and the possibility of recovery is considered remote.</div></div>
CY2023 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
363799
CY2022 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
125133
CY2023Q4 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
0
CY2022Q4 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
180000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
152000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10000
CY2023Q4 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
152000
CY2022Q4 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
190000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
445191
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
50000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
445191
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2023 lgiq Certificate Of Amendment Description
CertificateOfAmendmentDescription
Upon the filing of the Certificate of Amendment, and the resulting effectiveness of the Reverse Stock Split, every 13 outstanding shares of the Company’s Common Stock were, without any further action by the Company, or any holder thereof, combined into and automatically became 1 share of the Company’s Common Stock
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 lgiq Arithmetic Average Purchase Of Shares Percentage
ArithmeticAveragePurchaseOfSharesPercentage
0.97
CY2022Q1 lgiq Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
631579
CY2022Q1 lgiq Common Stock Percentage
CommonStockPercentage
0.015
CY2022Q1 us-gaap Other Commitment
OtherCommitment
40000000
CY2022Q1 lgiq Ownership Limitation Percentage
OwnershipLimitationPercentage
0.0999
CY2022Q1 us-gaap Stock Issued1
StockIssued1
37000000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
132326
CY2022Q4 us-gaap Share Price
SharePrice
0.0001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
92737101
CY2023Q4 us-gaap Share Price
SharePrice
0.0001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
4000000
CY2023Q4 us-gaap Share Price
SharePrice
0.0001
CY2020Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
35714285
CY2020Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
14284714
CY2020Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
564467
CY2020Q4 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
5000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 lgiq Total Shares Of Common Stock
TotalSharesOfCommonStock
51762839
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
3550000
CY2019Q4 us-gaap Share Price
SharePrice
0.0001
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
404439
CY2020Q4 us-gaap Share Price
SharePrice
0.0001
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
2788972
CY2022Q4 us-gaap Share Price
SharePrice
0.0001
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
132326
CY2023Q4 us-gaap Share Price
SharePrice
0.0001
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
4000000
CY2023Q4 us-gaap Share Price
SharePrice
0.0001
CY2023 lgiq Vesting Period On Monthly Basis
VestingPeriodOnMonthlyBasis
P5Y
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
250000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.6
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.8
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y8M1D
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
250000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.6
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.8
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-16409919
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9951377
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3686308
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-19511632
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20096227
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29463009
CY2023 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
The weighted average number of shares of common stock has been retroactively restated to reflect the 1 for 13 reverse stock-split on February 25, 2020.
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2022 lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11663762
CY2023 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25711991
CY2022 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
23006480
CY2021 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2023 lgiq Data Logiq Spinoff Description
DataLogiqSpinoffDescription
At Closing Abri will deliver to the Company $114 million worth of shares Abri common stock, par value $0.0001, at $10.00 per share (the “Merger Consideration Shares”). Also at Closing, the Company will issue a dividend to its shareholders on a pro-rata basis equal to 25% of the aggregate Merger Consideration Shares (the “Dividend Shares”), payable to the Company shareholders of record as of a record date to be set shortly before Closing.
CY2023Q2 us-gaap Tangible Capital Required For Capital Adequacy
TangibleCapitalRequiredForCapitalAdequacy
5000001
CY2023Q3 lgiq Percentage Of Merger Consideration Shares Required To Distribute
PercentageOfMergerConsiderationSharesRequiredToDistribute
0.14
CY2023Q4 us-gaap Shares Issued
SharesIssued
3762000
CY2023 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
11663762
CY2022 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
25711991
CY2023 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
10790605
CY2022 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
19776533
CY2023 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
873157
CY2022 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
5935458
CY2023 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
1165532
CY2022 us-gaap Disposal Group Including Discontinued Operation Depreciation And Amortization
DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
10871495
CY2023 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
3806844
CY2022 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
10245047
CY2023 lgiq Disposal Group Including Discontinued Operation Sales And Marketing
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing
60000
CY2022 lgiq Disposal Group Including Discontinued Operation Sales And Marketing
DisposalGroupIncludingDiscontinuedOperationSalesAndMarketing
1210233
CY2023 lgiq Disposal Group Including Discontinued Operation Research And Development
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
0
CY2022 lgiq Disposal Group Including Discontinued Operation Research And Development
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
3116723
CY2023 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
5032376
CY2022 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
25443498
CY2023 lgiq Disposal Group Including Discontinued Operation Other Expensesincome Net
DisposalGroupIncludingDiscontinuedOperationOtherExpensesincomeNet
132063
CY2022 lgiq Disposal Group Including Discontinued Operation Other Expensesincome Net
DisposalGroupIncludingDiscontinuedOperationOtherExpensesincomeNet
3592
CY2023 lgiq Net Loss From Discontinued Operations
NetLossFromDiscontinuedOperations
-4291282
CY2022 lgiq Net Loss From Discontinued Operations
NetLossFromDiscontinuedOperations
-19511632
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
13322699
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
5246231
CY2023Q4 lgiq Net Assets Of Disposal Group Including Discontinued Operations
NetAssetsOfDisposalGroupIncludingDiscontinuedOperations
8076468
CY2023Q4 lgiq Capital Reserve Of Disposal Group Including Discontinued Operations
CapitalReserveOfDisposalGroupIncludingDiscontinuedOperations
-7471494
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
604974
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001575872-24-000488-index-headers.html Edgar Link pending
0001575872-24-000488-index.html Edgar Link pending
0001575872-24-000488.txt Edgar Link pending
0001575872-24-000488-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lg033_10kimg01.jpg Edgar Link pending
lg033_ex23-1.htm Edgar Link pending
lg033_ex23-1img01.jpg Edgar Link pending
lg033_ex23-1img02.jpg Edgar Link pending
lg033_ex31-1.htm Edgar Link pending
lg033_ex31-2.htm Edgar Link pending
lg033_ex32-1.htm Edgar Link pending
lg033_ex32-2.htm Edgar Link pending
lgiq-20231231.htm Edgar Link pending
lgiq-20231231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lgiq-20231231_cal.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
lgiq-20231231_lab.xml Edgar Link unprocessable
lgiq-20231231_pre.xml Edgar Link unprocessable
lgiq-20231231_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lgiq-20231231_def.xml Edgar Link unprocessable